Pages that link to "Q35188169"
Jump to navigation
Jump to search
The following pages link to The soluble guanylyl cyclase activator YC-1 increases intracellular cGMP and cAMP via independent mechanisms in INS-1E cells (Q35188169):
Displaying 4 items.
- Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study (Q34448355) (← links)
- Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial. (Q37510689) (← links)
- YC-1, a potent antithrombotic agent, induces lipolysis through the PKA pathway in rat visceral fat cells (Q54507209) (← links)
- Pharmacological modulation of the CO2/HCO3-/pH-, calcium-, and ATP-sensing soluble adenylyl cyclase (Q88882229) (← links)